WK

Wijeyasangary Kalamalini

Active Director Designated Partner DIN 10005772
DIN 10005772 First appointment Jun 2022 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Wijeyasangary Kalamalini

Data last updated:

Wijeyasangary Kalamalini is a Designated Partner at Udhayam Multi Speciality Hospital Llp (since 2022). The company operates in Healthcare.

DIN 10005772
Primary Designation Designated Partner
Industry Healthcare
First Appointment 08 Jun 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner08 Jun 20222022Active

Board colleagues of Wijeyasangary Kalamalini

Directorship timeline

Open interactive timeline →
Udhayam Multi Speciality Hospital Llp
Premium access

Shareholding and investment profile for Wijeyasangary Kalamalini

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Wijeyasangary Kalamalini

Wijeyasangary Kalamalini currently holds 1 directorship: Udhayam Multi Speciality Hospital Llp (Designated Partner, since 08 Jun 2022).

Wijeyasangary Kalamalini was first appointed on 08 Jun 2022 as Designated Partner at Udhayam Multi Speciality Hospital Llp.

The current boards of Wijeyasangary Kalamalini's companies include Arunachalam Chandramohan (Udhayam Multi Speciality Hospital Llp), Tharmasangary Wijeyasangary (Udhayam Multi Speciality Hospital Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available